Ability Inc. Announces Dual Listing on the Tel Aviv Stock Exchange
Jan 08, 2016 13:39 pm UTC| Business
Ordinary shares currently are listed on NASDAQ and will be listed on the Tel Aviv Stock Exchange (TASE) beginning January 12, 2016 under ticker symbol ABIL NEW YORK and TEL AVIV, Israel, Jan. 08, 2016 (GLOBE NEWSWIRE)...
Victory Nickel Announces TSX Delisting Decision
Jan 08, 2016 13:35 pm UTC| Business
TORONTO, Jan. 8, 2016 (GLOBE NEWSWIRE) -- Victory Nickel Inc. ("Victory Nickel" or the "Company") (TSX:NI, www.victorynickel.ca) today announced that the Toronto Stock Exchange ("TSX") has determined to delist the...
RAADR, Inc. Retains Evolve Public Relations and Marketing to Increase Subscriber Base
Jan 08, 2016 13:30 pm UTC| Business
Phoenix, AZ, Jan. 08, 2016 (GLOBE NEWSWIRE) -- -- RAADR, Inc. (OTCQB: RDAR), a technology and software development company that monitors cyber bullying and social media platforms through its artificially intelligent...
Jan 08, 2016 13:30 pm UTC| Business
SANTA MONICA, Calif., Jan. 08, 2016 (GLOBE NEWSWIRE) -- A-Mark Precious Metals, Inc. (NASDAQ:AMRK), a full-service precious metals trading company, will hold its 2016 Annual Meeting of Stockholders on Tuesday, February...
OncoMed Announces Publication of Anti-RSPO Antibody Research in Cancer Research
Jan 08, 2016 13:30 pm UTC| Business
REDWOOD CITY, Calif., Jan. 08, 2016 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals Inc. (NASDAQ:OMED), a clinical-stage company developing novel anti-cancer stem cell and immuno-oncology therapeutics, today announced the...
Jan 08, 2016 13:30 pm UTC| Business
LEESBURG, Va., Jan. 08, 2016 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (Nasdaq:KTWO), a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine...
Novavax Appoints Jeffrey Stoddard, M.D., Vice President, Medical Affairs
Jan 08, 2016 13:30 pm UTC| Business
GAITHERSBURG, Md., Jan. 08, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and...